Palo Alto Investors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.4M | Sell |
|
|||||
2025
Q1 | $32.4M | Sell |
|
|||||
2024
Q4 | $54.9M | Sell |
|
|||||
2024
Q3 | $65.7M | Sell |
|
|||||
2024
Q2 | $85M | Sell |
|
|||||
2024
Q1 | $61.5M | Sell |
|
|||||
2023
Q4 | $87M | Sell |
|
|||||
2023
Q3 | $130M | Sell |
|
|||||
2023
Q2 | $139M | Hold |
|
|||||
2023
Q1 | $141M | Buy |
|
|||||
2022
Q4 | $174M | Sell |
|
|||||
2022
Q3 | $133M | Sell |
|
|||||
2022
Q2 | $150M | Sell |
|
|||||
2022
Q1 | $117M | Sell |
|
|||||
2021
Q4 | $148M | Hold |
|
|||||
2021
Q3 | $127M | Hold |
|
|||||
2021
Q2 | $123M | Hold |
|
|||||
2021
Q1 | $115M | Sell |
|
|||||
2020
Q4 | $119M | Hold |
|
|||||
2020
Q3 | $79.3M | Buy |
|
|||||
2020
Q2 | $92.7M | Sell |
|
|||||
2020
Q1 | $83.1M | Sell |
|
|||||
2019
Q4 | $114M | Sell |
|
|||||
2019
Q3 | $114M | Sell |
|
|||||
2019
Q2 | $121M | Sell |
|
|||||
2019
Q1 | $192M | Hold |
|
|||||
2018
Q4 | $178M | Buy |
|
|||||
2018
Q3 | $208M | Hold |
|
|||||
2018
Q2 | $184M | Buy |
|
|||||
2018
Q1 | $182M | Buy |
|
|||||
2017
Q4 | $238M | Sell |
|
|||||
2017
Q3 | $207M | Sell |
|
|||||
2017
Q2 | $242M | Sell |
|
|||||
2017
Q1 | $255M | Buy |
|
|||||
2016
Q4 | $268M | Buy |
|
|||||
2016
Q3 | $208M | Buy |
|
|||||
2016
Q2 | $182M | Buy |
|
|||||
2016
Q1 | $170M | Buy |
|
|||||
2015
Q4 | $238M | Sell |
|
|||||
2015
Q3 | $200M | Buy |
|
|||||
2015
Q2 | $250M | Buy |
|
|||||
2015
Q1 | $247M | Buy |
|
|||||
2014
Q4 | $182M | Buy |
|
|||||
2014
Q3 | $167M | Buy |
|
|||||
2014
Q2 | $107M | Buy |
|
|||||
2014
Q1 | $104M | Buy |
|
|||||
2013
Q4 | $124M | Buy |
|
|||||
2013
Q3 | $83.9M | Buy |
|
|||||
2013
Q2 | $59.3M | Buy |
|